Avalo Therapeutics (AVTX) Net Equity Issued and Repurchased (2016 - 2023)

Avalo Therapeutics (AVTX) posted Net Equity Issued and Repurchased of $25.9 million for Q3 2023, up 70105305.41% on a QoQ basis from $37.0 in Q4 2020.

Avalo Therapeutics (AVTX) Net Equity Issued and Repurchased (2016 - 2023) Analysis & Trends

Avalo Therapeutics' Net Equity Issued and Repurchased history runs 5 years deep, the most recent figure standing at $25.9 million for Q3 2023.

  • Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $25.9 million in Q3 2023, while the trailing twelve-month figure through Dec 2024 was $25.9 million (changed 0.0% YoY) and the FY2025 annual result came in at $14.8 million, changed N/A from the prior year.
  • Net Equity Issued and Repurchased was $25.9 million for Q3 2023 at Avalo Therapeutics, up from $37.0 in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $35.4 million in Q2 2020 and bottomed at -$37.0 in Q3 2020.
  • A 3-year average of $14.1 million and a median of $9.0 million in 2019 frame the typical range for Net Equity Issued and Repurchased.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 163.10 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 141.90 Mn
10 Avalo Therapeutics 1.04 Mn 1.04 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2023 25.94 Mn
Sep 30, 2023 25.94 Mn
Dec 31, 2020 37.00
Dec 31, 2020 37.00
Sep 30, 2020 -37.00
Sep 30, 2020 -37.00
Jun 30, 2020 35.43 Mn
Jun 30, 2020 35.43 Mn
Mar 31, 2019 8.98 Mn
Mar 31, 2019 8.98 Mn
Jun 30, 2017 506,934.00
Jun 30, 2017 506,934.00
Mar 31, 2017 1.19 Mn
Mar 31, 2017 1.19 Mn
Dec 31, 2016 900,000.00
Dec 31, 2016 900,000.00
Sep 30, 2016 900,000.00
Sep 30, 2016 900,000.00